Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W. Merryman, Alex F. Herrera, Robert Redd et al.|Blood Advances|2021Cited by 51
Low booster uptake in cancer patients despite health benefitsJane C. Figueiredo, Akil Merchant, Carissa A. Huynh et al.|iScience|2024Cited by 2
Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaReid W. Merryman, Alex F. Herrera, Robert Redd et al.|Blood|2019Cited by 2
Supplementary Data from Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with CancerJane C. Figueiredo, Akil Merchant, Noah Merin et al.|Unknown|2023Cited by 0
Data from Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with CancerJane C. Figueiredo, Akil Merchant, Noah Merin et al.|Unknown|2023Cited by 0